USPTO Patent Application: Modified Release Minoxidil Formulations

ChangeBridge: Patent Apps - Pharma (A61K)

Published March 26th, 2026

Detected March 26th, 2026

Summary

The USPTO has published a patent application (US20260083737A1) detailing modified release minoxidil oral formulations and methods for treating hair loss. The application describes pharmaceutical compositions containing minoxidil or its salts, potentially with other active agents, and includes methods for their administration and related kits.

View original document View source feed page

What changed

This document is a USPTO patent application (US20260083737A1) filed on November 26, 2025, and published on March 26, 2026. It describes novel pharmaceutical formulations for oral administration of modified-release minoxidil, including compositions with additional active agents and methods for treating hair loss. The application also covers kits containing slow modified-release vehicles with oral minoxidil.

As this is a patent application, it does not impose immediate compliance obligations on regulated entities. However, it signals potential future intellectual property and market exclusivity for specific drug formulations related to hair loss treatment. Companies in the pharmaceutical sector, particularly those involved in dermatology or hair loss treatments, should monitor the progress of this and similar patent applications.

Source document (simplified)

← USPTO Patent Applications

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

Application US20260083737A1 Kind: A1 Mar 26, 2026

Inventors

Reid WALDMAN

Abstract

The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.